Group-Sequential Clinical Trials with Multiple Co-Objectives

Nonfiction, Health & Well Being, Medical, Reference, Biostatistics, Science & Nature, Mathematics, Statistics
Cover of the book Group-Sequential Clinical Trials with Multiple Co-Objectives by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura, Springer Japan
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura ISBN: 9784431559009
Publisher: Springer Japan Publication: June 1, 2016
Imprint: Springer Language: English
Author: Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
ISBN: 9784431559009
Publisher: Springer Japan
Publication: June 1, 2016
Imprint: Springer
Language: English

This book focuses on group sequential methods for clinical trials with co-primary endpoints based on the decision-making frameworks for: (1) rejecting the null hypothesis (stopping for efficacy), (2) rejecting the alternative hypothesis (stopping for futility), and (3) rejecting the null or alternative hypothesis (stopping for either futility or efficacy), where the trial is designed to evaluate whether the intervention is superior to the control on all endpoints. For assessing futility, there are two fundamental approaches, i.e., the decision to stop for futility based on the conditional probability of rejecting the null hypothesis, and the other based on stopping boundaries using group sequential methods. In this book, the latter approach is discussed. The book also briefly deals with the group sequential methods for clinical trials designed to evaluate whether the intervention is superior to the control on at least one endpoint. In addition, the book describes sample size recalculation and the resulting effect on power and type I error rate. The book also describes group sequential strategies for three-arm clinical trials to demonstrate the non-inferiority of experimental intervention to actively control and to assess the assay sensitivity to placebo control.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book focuses on group sequential methods for clinical trials with co-primary endpoints based on the decision-making frameworks for: (1) rejecting the null hypothesis (stopping for efficacy), (2) rejecting the alternative hypothesis (stopping for futility), and (3) rejecting the null or alternative hypothesis (stopping for either futility or efficacy), where the trial is designed to evaluate whether the intervention is superior to the control on all endpoints. For assessing futility, there are two fundamental approaches, i.e., the decision to stop for futility based on the conditional probability of rejecting the null hypothesis, and the other based on stopping boundaries using group sequential methods. In this book, the latter approach is discussed. The book also briefly deals with the group sequential methods for clinical trials designed to evaluate whether the intervention is superior to the control on at least one endpoint. In addition, the book describes sample size recalculation and the resulting effect on power and type I error rate. The book also describes group sequential strategies for three-arm clinical trials to demonstrate the non-inferiority of experimental intervention to actively control and to assess the assay sensitivity to placebo control.

More books from Springer Japan

Cover of the book Bifurcation Theory for Hexagonal Agglomeration in Economic Geography by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Total Synthesis of Thielocin B1 as a Protein-Protein Interaction Inhibitor of PAC3 Homodimer by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Introduction to Earth and Planetary System Science by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Pain and Kampo by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Liver Diseases and Hepatic Sinusoidal Cells by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book The Cadherin Superfamily by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Development of New Catalytic Performance of Nanoporous Metals for Organic Reactions by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Anionic Polymerization by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Analysis of the Electric Dipole Moment in the R-parity Violating Supersymmetric Standard Model by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Esophageal Squamous Cell Carcinoma by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Smart Biomaterials by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Mechanism of Artificial Heart by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Theoretical Aspects of Spatial-Temporal Modeling by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Progress in Hepatocellular Carcinoma Treatment by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
Cover of the book Sugar Chains by Toshimitsu Ochiai, Scott R. Evans, Toshimitsu Hamasaki, Koko Asakura
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy